SCHEDULE: Perceptive Advisors Divests Astria Therapeutics Stake
Ownership Change Report
Perceptive Advisors and related entities have reported zero beneficial ownership in Astria Therapeutics following its acquisition by BioCryst.
Summary
- Reporting Persons, including Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., and Perceptive Xontogeny Venture Fund, L.P., no longer beneficially own any shares of Astria Therapeutics, Inc.
- This change in beneficial ownership is a direct result of the consummation of the previously announced acquisition of Astria Therapeutics by BioCryst pursuant to a Merger Agreement.
- The merger was completed on January 23, 2026, at which point Astria Therapeutics ceased to exist as a separate entity.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a factual update on a completed, previously announced corporate action (a merger) and does not contain new operational or financial performance data.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that the completion of the BioCryst acquisition of Astria Therapeutics signifies further consolidation within the biotechnology sector, a common trend as larger pharmaceutical companies seek to integrate promising smaller firms to expand their pipelines or market share.
Stakeholder Impact
- Shareholders of Astria Therapeutics, Inc. no longer hold shares in the company as it ceased to exist as a separate entity following the merger with BioCryst.
Key Dates
| Date | Description |
|---|---|
| 01/23/2026 | Completion of the acquisition of Astria Therapeutics, Inc. by BioCryst pursuant to the Merger Agreement. |
| 01/26/2026 | Date of event requiring the filing of this Schedule 13D, marking the change in beneficial ownership. |
| 02/09/2026 | Date of signing for the Schedule 13D Amendment No. 7 by the Reporting Persons. |
Keywords
Astria Therapeutics, BioCryst, Merger, Acquisition, Perceptive Advisors, Schedule 13D, Divestment, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.